April 15 -17, 2025

Hyatt Regency | Indianapolis, Indiana

Follow us for updates & more information!

Human Papillomavirus (HPV) is known to cause six types of cancers in all genders. Despite availability of a vaccine, the U.S. continues to see an alarming rate of HPV transmission and HPV-related cancers. Professionals at the national, regional, state, and local levels are working tirelessly on evidence-based practices and want to collaborate with others to increase prevention, early detection, and treatment of HPV-related diseases.

The goal of this inaugural conference is to invite all U.S. professionals working in the HPV space to come together in an effort to learn and share. While many conferences strive to include HPV as one of many topics, this conference seeks to make HPV the main topic. Attendees will enjoy learning and connecting with peers, while forming new ideas and partnerships to make their own HPV-related efforts stronger.

Together, we can strive to eliminate HPV-related diseases and cancers in the U.S.

Hosted By

Indiana Immunization Coalition Logo

National Planning Committee

These partners are working to make the National HPV Conference a more comprehensive and valuable experience for all participants.

The national planning committee consists of members from:

  • American Cancer Society
  • American Cancer Society National Roundtable on Cervical Cancer
  • American Cancer Society National HPV Vaccination Roundtable
  • Centers for Disease Control and Prevention
  • Global Initiative Against HPV and Cervical Cancer
  • Indiana Immunization Coalition
  • National Cancer Institute
  • National Council of Negro Women
  • Recurrent Respiratory Papillomatosis Foundation
  • St. Jude Children’s Research Hospital
  • Unity Consortium

    About the Conference

    Expected Outcomes

    The National HPV Conference was established to create a venue for networking, dissemination of best practices, resource sharing, and cross collaboration in a way never done before in the United States. We are excited for the opportunity to have HPV champions across key sectors convene together to advance HPV prevention efforts nationally. This inaugural conference will allow participants to:

    • Connect with like-minded people from across the country
    • Share and learn from others’ experiences
    • Stimulate new ideas
    • Identify ways to collaborate locally and across state lines
    • Develop actionable work plans to implement at home
    • Unite in efforts to achieve our central goal of eliminating HPV infections in the U.S.
    Intended Audience

    The intended audience for this conference is wide-reaching by design. The goal of the conference is to convene professionals who work in many different areas of the HPV continuum in an effort to create partnerships and collaboration. During this inaugural conference, we anticipate 350-500 attendees. The gathering is specifically aimed at professionals in the U.S. who work in and with the public regarding HPV. Some examples of these professionals are:

    • Advocates
    • Community Health Workers
    • Epidemiologists
    • Health Educators
    • Health Policy Professionals
    • Healthcare Providers, e.g.:
      • Nurses
      • Physicians
      • Social Workers
      • Navigators
      • Pharmacists
      • Dentists
      • Healthcare students / trainees
    • Local, Regional, and National
      Stakeholder Groups
    • Public Health Organizations
    • Reproductive and Sexual Health Organizations
    • Researchers, e.g.:
      • Dissemination, Implementation, and
        Translational Sciences
      • Health Behavior
      • Health Communication
      • Health Informatics
      • Health Psychology
      • Promotion and Marketing
      • Public Health

    Guest Speakers

    Focus Tracks

    Vaccination and Prevention

    This track will focus on measures to prevent HPV infection, including education and awareness, advocacy, policy, vaccination, sexual health, health disparities, and more. Speakers will be encouraged to share programs, practices, and materials that have been successful in the realm of HPV prevention. Participants will leave with new ideas and actionable items.

    Research and Best Practices

    This track invites area experts and researchers to present findings directly related to public-facing HPV care and prevention. Presentations should not be overly technical, but should privilege projects that include evaluation data, consensus statements, or similar approaches to establishing best practices. Applicable topics might include health equity, best practices, health communication, dissemination, or implementation science.

    Cancer Screening and Treatment

    This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.

    Public Health and Collaboration

    This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.

    Day 1

    Day 2

    Day 3

    Call for Abstracts

    Abstract submission closed on October 15th at 8 PM ET.

    Additional posters may be accepted in early Spring if space allows. Sign up for updates
    • Call for abstracts submissions open: June 15, 2024. 
    • Deadline for abstract submission: September 15, 2024 October 15, 2024 at 8pm ET. 
    • Deadline for reviewers to complete abstract reviews: October 15, 2024 November 15, 2024 at 8pm ET.
    • Program decisions will go out on or before November 15, 2024 December 20, 2024.

    Registration

    Regular Ticket: Early $400 / Regular $500 / Late $600

    Student Ticket: Early $200 / Regular $250

    Early: September 6 – January 15  |  Regular: January 16 – March 31 |  Late: April 1 – Conference

    Register Now on Whova

    Sponsor or Exhibit

    View the prospectus here

    Thank you for your sponsorship consideration. This is your opportunity to engage with a targeted audience of professionals eager to make a difference in the HPV arena. Sponsorship not only provides exposure and networking for your organization, but also provides the financial support necessary to offer this conference at a reasonable, accessible price for all attendees.

    CONFERENCE LOCATION

    Hyatt Regency Indianapolis  |   1 S. Capitol Avenue, Indianapolis, IN 46204

    The hotel is located in downtown Indianapolis, less than 15 miles from the IND airport. Indiana is known as the “Crossroads of America” due to its central location and ease of accessibility by car or airplane. Downtown Indianapolis features an exciting assortment of restaurants, museums, and cultural attractions, making it a prime conference destination. Find out more about Indianapolis at www.visitindy.com

    Use the links below to reserve your room

    Government per diem rates are for qualified government employees. ID may be required at check-in. 
    Conference registration and hotel reservations are separate. Make sure to register for the conference here.